RecallClass 4 · Caution in use

Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24

Issued 14 May 2026 · EL(26)A/24 · Fresenius Medical Care Deutschland GmbH

Read and act on the official notice on GOV.UK

Class 4 recall — Caution in use. The MHRA uses Class 4 when: Usually minor defects in packaging or other printed materials.
What all four recall classes mean
ClassActionThe MHRA's definition
Class 1Immediate actionThe defect presents a risk of death or disability.
Class 2Action within 48 hoursThe defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious.
Class 3Action within 5 daysThe defect is unlikely to cause harm to the patient.
Class 4 this recallCaution in useUsually minor defects in packaging or other printed materials.

A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.

The MHRA's summary

Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label.

Affected batches

As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.

Batch numberExpiryPack sizeFirst distributed
balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis
F4LM07111/20262 x 5ltr bags04/02/2025
G4LB13301/20272 x 5ltr bags01/07/2025
G4LL14410/20272 x 5ltr bags26/01/2026
G4LM15211/20272 x 5ltr bags23/02/2026
H4LB21211/20282 x 5ltr bags07/05/2026
G4LI15108/20272 x 5ltr bags26/01/2026

MHRA's audience tags: Dispensing GP practices, Pharmacy, Renal medicine

Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice.

Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.